Viewing StudyNCT06095375



Ignite Creation Date: 2024-05-06 @ 7:41 PM
Last Modification Date: 2024-10-26 @ 3:11 PM
Study NCT ID: NCT06095375
Status: RECRUITING
Last Update Posted: 2024-02-12
First Post: 2023-03-10

Brief Title: Regorafenib With Temozolomide With or Without RT in MGMT-Methylated IDH Wild-type GBM Patients
Sponsor:
Organization: Istituto Oncologico Veneto IRCCS

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 36
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: